Table of contents |
Go straight to the enquiries: |
81-07-2 | ||
201-321-0 | ||
E 954 | ||
1,2-Benzisothiazol-3(2H)-on-1,1-dioxid | ||
According to literature about 300-700 times sweeter than sugar. According to our manufacturer, it is 550 times. | ||
C7H5NO3S | ||
183.18 g/mol | ||
228.8-229.7 °C | ||
0.828 g/cm³ | ||
1/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9) | ||
CVHZOJJKTDOEJC-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2 | ||
O=C1NS(=O)(=O)C=2C=CC=CC12 | ||
29251100 |
128-44-9 | ||
204-886-1 | ||
E 954 | ||
Sodium saccharin unhydrous | ||
Natrium-1,2-benzothiazol-3-olat-1,1-dioxid | ||
However, the anhydrous variant is not usually sold, but is often used as a synonym for the hydrates. The dihydrate is very common in practice. | ||
C7H5NO3S.Na | ||
183,18 g/mol | ||
Decomposition at about 226+ °C. | ||
approx. 600–800 g/L | ||
1S/C7H5NO3S.Na/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;/h1-4H,(H,8,9); | ||
IDIPRSBHIGCTDN-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2.[Na] | ||
[Na].O=C1NS(=O)(=O)C=2C=CC=CC12 | ||
29251100 |
82385-42-0 | ||
204-886-1 (gelegentlich auch 617-325-4) | ||
Sodium saccharin X-hydrate | ||
1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, hydrate | ||
C7H5NO3S.xH2O.Na | ||
223.17 g/mol (Monohydrat) bzw. 217,2 (2/3 Hydrat ~ 6% Wasser) | ||
ca. 226 – 230 °C. | ||
6–7,5 @ 10%w/v, 20 °C | ||
1S/C7H5NO3S.Na.H2O/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;;/h1-4H,(H,8,9);;1H2 | ||
ADGODYTXWSFUEZ-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2.[Na].O | ||
[Na].O=C1NS(=O)(=O)C=2C=CC=CC12.O | ||
29251100 |
6155-57-3 | ||
612-173-5 | ||
Sodium saccharin dihydrate | ||
Sodium-3-oxo-3H-1λ4,2-benzothiazol-1-olat-1-oxidhydrat- (1:1:2) | ||
C7H5NO3S.2H2O.Na | ||
241,2 (Dihydrat) | ||
ca. 226 – 230 °C. | ||
600–800 g/L | ||
1S/C7H5NO3S.Na.2H2O/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;;;/h1-4H, | ||
UQKRDMFNUSMUCB-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2.[Na].O | ||
[Na].O=C1NS(=O)(=O)C=2C=CC=CC12.O | ||
29251100 |
6485-34-3 | ||
229-349-9 | ||
Calcium saccharin | ||
Calciumbis(1,2-benzothiazol-3-olat-1,1-dioxid)%B | ||
Less soluble in water than sodium saccharin, but soluble in hot water (approx. 1 g in 1.5 ml). | ||
Used in tablets and food supplements where an easily soluble source of calcium is required. | ||
C14H8CaN2O6S2 | ||
404.431 g/mol | ||
438.9 °C | ||
219.3 °C | ||
1S/C7H5NO3S.Ca/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;/h1-4H,(H,8,9); | ||
GSHUZVSNIBLGMR-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2.[Ca] | ||
[Ca].O=C1NS(=O)(=O)C=2C=CC=CC12 | ||
29251100 |
6381-91-5 | ||
(625-316-1) | ||
Calcium Saccharin hydrate | ||
Calciumbis(1,2-benzothiazol-3-olat-1,1-dioxid)hydrat- (2:7)%B | ||
Stable at high temperatures, therefore suitable for cooking and baking. Similar to calcium saccharin anhydrous. Used in tablets and food supplements where an easily soluble source of calcium is required. | ||
C14H8CaN2O6S2·xH2O (hydrate depending on the amount of water) | ||
422.44600 (Monohydrate) | ||
136°C | ||
1S/C7H5NO3S.Ca.H2O/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;;/h1-4H,(H,8,9);;1H2 | ||
FJCBEDPGTMUUQL-UHFFFAOYSA-N | ||
O=S1(=O)C=2C(C(=O)N1)=CC=CC2.[Ca].O | ||
[Ca].O=C1NS(=O)(=O)C=2C=CC=CC12.O | ||
29251100 |
In particular, the discussion regarding a possible carcinogenic effect of saccharin is based on various studies, some of which were carried out under very different conditions.
Early studies from 1977 were criticized due to the very high doses fed to the rats, which often exceeded the normal consumption of a human by a
hundredfold. It was also shown that the biological mechanism that causes cancer in rats cannot be directly transferred to humans due to the different
composition of urine.
Other epidemiological studies have not confirmed a link between saccharin consumption and increased cancer rates (especially bladder cancer). No
study has been able to confirm health risks in humans (when consuming normal doses). A meta-study from 2004 classifies a possible cancer risk as
insignificant.
Over 25 years ago, saccharin was classified as “not classifiable as to its carcinogenicity to humans” by the International Agency for Research on Cancer
(IARC). Even more recent findings have not changed this. In many countries, saccharin is approved for sale and consumption without restriction.
For more information on this topic, see Wikipedia – Saccharin
The permitted daily dose of saccharin is 5 mg/kg body weight. The designation as a food additive is “E 954”
The sweetening power of saccharin compared to sugar is 300 to 700 times (depending on the variant).
Saccharin remains stable when heated (unlike the newer artificial sweetener aspartame), even in combination with acids. Its stability makes it easy to store. Saccharin does not cause tooth decay. After ingestion, saccharin is mainly absorbed directly and is quickly taken up by the bloodstream. It enters the entire body by binding to plasma proteins and is almost completely excreted in the urine after just one day through renal elimination. Remaining residues are excreted in the stool.
Like all sweeteners, saccharin has virtually no physiological energy content, is therefore also suitable for diabetics and is therefore used as a sweetener in dietary foods and light products. It may only be used in certain foods with defined maximum levels. Some of these limits are, for example, 200 mg/kg for jams, 160 mg/kg for canned fruit and vegetables and 80 mg/l for energy-reduced drinks.
For those who want to use saccharin industrially (whether for food, the pharmaceutical industry, cosmetics or pet food) and require quantities ranging from individual containers (approx. 25 kg) to several pallets (up to approx. 10 tons in total) and also prefer excellent quality from European production, together with extensive documentation, they have a good chance of finding what they are looking for with us (to the inquiries).
For customers with somewhat lower requirements, we also offer products from Asian production. Further information can be found under ‘Information about Saccharin Sodium, Dihydrate’.